From Exhibit to Market: Johnson & Johnson's Impella® Percutaneous Left Ventricular Assist Device Cleared Customs and Enters Clinical Use in China

Introduction

China Builds the Stage, the World Sings Together. Since 2018, the China International Import Expo (CIIE) has been successfully held for eight consecutive sessions, becoming the premier launchpad for global new products, a preferred site for cutting-edge technologies, and a leading platform for innovative services. Under the powerful spillover and driving effects of the CIIE, numerous exhibits have accelerated their market entry, achieving rapid transformation from booths to shelves, from farms to dining tables, and from concepts to reality. The column "From Exhibits to Goods" documents, based on reports from various media, the vivid practice of high-quality development and the creation of a high-standard living driven by global fine products at "CIIE speed."

Recently, Johnson & Johnson Impella®The Interventional Left Ventricular Assist Pump Has Cleared Customs at Tianzhu.

Johnson & Johnson Impella®The interventional left ventricular assist pump is currently the world's only FDA-approved interventional ventricular assist device, known as "the world's smallest heart pump."This product is mainly used for treating patients with severe coronary artery disease, those in need of high-risk PCI surgery, or those experiencing cardiogenic shock. It can provide effective circulatory support to significantly improve the success rate of rescue and enhance the survival chances of patients.

It is reported that the batch of medical devices has been put into use in Beijing Fuwai and Anzhen hospitals and officially used for clinical treatment. "Currently, a large amount of evidence-based medicine...And clinical evidence proves that Impella®The interventional left ventricular assist pump is a relatively safe and effective short-term assist device.The device willBring new treatment options to critically ill heart failure patients."Director of the Adult Surgical Center at Fuwai Hospital and Chief Physician, Wang Xianqiang, stated."

Cardiovascular and cerebrovascular diseases are the number one killer threatening human health and a difficult problem that the medical community urgently needs to solve.Impella®The interventional left ventricular assist pump, an innovative product showcased by Johnson & Johnson for the first time at the 7th CIIE, can provide strong assistance to patients with severe heart failure who are waiting for a heart transplant.

Source: Xinhua News Agency, Beijing Daily

The China International Import Expo Bureau (hereinafter referred to as "CIIE Bureau"), as the official organization of CIIE, releases the series of content "Exhibits Turn into Commodities" for free with non-profit purposes.